Xepa-Soul Pattinson

Xepa-Soul Pattinson is a leading Malaysian pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality generic finished dosage forms. Established in 1967, the company operates a state-of-the-art GMP-certified manufacturing facility in Melaka, producing a wide range of therapeutic products including liquids, solids, and semi-solids. As a core subsidiary of Apex Healthcare Berhad, Xepa-Soul Pattinson serves both the domestic Malaysian market and numerous international markets across Southeast Asia and beyond. Their portfolio covers diverse therapeutic areas such as respiratory, cardiovascular, and anti-infectives, supported by robust research and development in generic formulation. The company is recognized for its adherence to international quality standards, including EU-GMP certification for certain production lines.